News & Updates

VIATRIS MASTERCLASS 2024 - EMERGING ASIA MEDICAL AFFAIRS (August 3rd & 4th, 2024 | Da Nang, Vietnam)

Lomitapide lowers LDL-C levels in paediatric homozygous familial hypercholesterolaemia

Children with homozygous familial hypercholesterolaemia (HoFH) achieve significant and clinically meaningful reductions in low-density lipoprotein cholesterol (LDL-C) with the microsomal triglyceride transfer protein (MTP) inhibitor lomitapide, which represents an efficient LDL receptor-independent treatment option, according to the open-label phase III APH-19 trial.

Original New Drug Application Approvals by US FDA (16-31 October 2024)

New drug applications approved by US FDA as of 16-31 October 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Vitamin K2 supplementation eases leg cramps in seniors

Daily supplementation with vitamin K2 helps minimize the frequency, intensity, and duration of nocturnal leg cramps in older adults while having a good safety profile, as shown in a study.

Black coffee helps prevent metabolic syndrome in women

Drinking 2 to 3 cups of black coffee daily appears protective against metabolic syndrome (MetS) in women, potentially due to its positive impact on high-density lipoprotein cholesterol (HDL-C) and triglycerides, suggests a Korea study.

Is rapid-rate oxaliplatin safer than standard infusion?

Rapid infusion of oxaliplatin appears to have minimal treatment modifications relative to standard administration but may lead to a higher incidence of peripheral neuropathy (PN), according to a study.

Hyperuricaemia linked to short-term readmission, mortality risk in HF

For patients with heart failure (HF), hyperuricaemia is a risk factor for an increase in the risk of short-term hospital readmission and mortality, as reported in a retrospective study.

Beyond medication dispensing: The expanding role of pharmacists in healthcare

In celebration of World Pharmacists Day on September 25, Kenvue brought together a panel of experts to discuss how pharmacists are contributing in significant ways to delivering effective, accessible healthcare and improving patient outcomes. Mr Paul Sinclair, President of the International Pharmaceutical Federation, identified the roles pharmacists play in primary healthcare. Dr Angeline Yong, Consultant Dermatologist and Dermatological Laser Surgeon, Angeline Yong Dermatology Clinic, Singapore, described pharmacists as trusted advisors guiding good skincare practices. Dr Giridhar Sethuraman, Chief Consultant Neonatologist at Neolife Children’s Hospital, Chennai, India, focused on the role of pharmacists in managing atopic dermatitis in children. Dr Edwin Heng, Periodontist at Farrer Park Medical Centre, Singapore, discussed the critical connection between oral health and overall well-being. Professor Mohammad Haniki from the Kulliyyah of Pharmacy, International Islamic University of Malaysia, emphasized the importance of training pharmacists to support smoking cessation efforts.